Now that its cashflow positive and beating their revenue targets they can start properly plugging it to institutional investors. Might even find a bit of research pop up. If any institutional investors like what they see, they will keep hassling Franky-boy for his shares as there is no need to do a capital raising - which is where instos normally get a decent stake.
I would expect an improved result for the next quarter. They already flagged lower 'cost of sales' so expecting around $3m net cash return next quarter.
They won't buy back Franks shares. I also doubt they will make another acquisition. Best to bed down the ones they already have. Otherwise all your focus is on integration and not sales.
Share price will probably faff around in the short term until something is communicated about the overhang, or until some research comes out, but its still worth a few multiples of the current share price.
Add to My Watchlist
What is My Watchlist?
